Variant report
Variant | nsv528974 |
---|---|
Chromosome Location | chr7:71813660-71838207 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs2944814 | chr7:71813660-71813661 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs113106818 | chr7:71813674-71813675 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs190276835 | chr7:71813710-71813711 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs181041590 | chr7:71813713-71813714 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs556658749 | chr7:71813714-71813715 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs578167158 | chr7:71813727-71813728 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs568206632 | chr7:71813745-71813746 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs560516275 | chr7:71813758-71813759 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs528380091 | chr7:71813808-71813809 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs540117273 | chr7:71813829-71813830 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs562019970 | chr7:71813840-71813841 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs529052911 | chr7:71813849-71813850 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs185530366 | chr7:71813904-71813905 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs190235617 | chr7:71813940-71813941 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs11362427 | chr7:71813948-71813949 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs73362963 | chr7:71813993-71813994 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs550959598 | chr7:71814015-71814016 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs566302636 | chr7:71814027-71814028 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs533785945 | chr7:71814099-71814100 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs555755671 | chr7:71814113-71814114 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs73362965 | chr7:71814126-71814127 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs73362966 | chr7:71814161-71814162 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs563782587 | chr7:71814167-71814168 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs556822353 | chr7:71814208-71814209 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs75923968 | chr7:71814214-71814215 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs539174258 | chr7:71814235-71814236 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs149632055 | chr7:71814249-71814250 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs3032183 | chr7:71814267-71814268 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs372550983 | chr7:71814268-71814269 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs201368746 | chr7:71814269-71814270 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs572305530 | chr7:71814285-71814286 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs59947653 | chr7:71814297-71814298 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs531014482 | chr7:71814301-71814302 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs57310284 | chr7:71814305-71814306 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs533136413 | chr7:71814307-71814308 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs550939346 | chr7:71814315-71814316 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs543032404 | chr7:71814322-71814323 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs555244425 | chr7:71814338-71814339 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs564511303 | chr7:71814353-71814354 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs182127118 | chr7:71814355-71814356 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs185254836 | chr7:71814429-71814430 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs543981075 | chr7:71814472-71814473 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs191926488 | chr7:71814490-71814491 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs562390707 | chr7:71814506-71814507 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs534102708 | chr7:71814522-71814523 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs144403720 | chr7:71814564-71814565 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs148599792 | chr7:71814584-71814585 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs184071639 | chr7:71814601-71814602 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs527257216 | chr7:71814603-71814604 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs77967714 | chr7:71814627-71814628 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Melanoma | 18172304 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Stenocardia | 21860640 | CNVD |
Vasospasm | 21860640 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 22495311 | CNVD |
Wilms tumour | 21544195 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Biliary cancer | 19435499 | CNVD |
Williams-beuren syndrome | 22470819 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Glioblastoma multiforme | 21750150 | CNVD |
Cancer | 21183584 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Gastric cancer | 24379144 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Lissencephaly | 21572526 | CNVD |
Breast cancer | 17603634 | CNVD |
Liposarcoma | 21253554 | CNVD |
Breast cancer | 16397240 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Low-grade fibromyxoid sarcoma | 0 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 21264507 | CNVD |
Shwachman-Diamond syndrome | 22934832 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Cutaneous malignant melanoma | 17690212 | CNVD |
Leukemia | 17361228 | CNVD |
Breast cancer | 16461572 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Malignant melanoma | 17690212 | CNVD |
Astrocytoma | 22246337 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21364760 | CNVD |
Prostate cancer | 16461572 | CNVD |
Acute monocytic leukemia | 16498392 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Multiple myeloma | 17550852 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Bladder cancer | 21909424 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164920 | CNVD |
Prostate cancer | 18632612 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Chordoma | 18071362 | CNVD |
Williams Syndrome | 20824207 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Breast cancer | 22522925 | CNVD |
Breast cancer | 21990379 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Williams Syndrome | 16773131 | CNVD |
Breast cancer | 16417655 | CNVD |
Rheumatoid arthritis | 21728841 | CNVD |
Congenital abnormalities | 21549014 | CNVD |
Developmental delay | 18414209 | CNVD |
Developmental delay | 21549014 | CNVD |
Mental retardation | 18414209 | CNVD |
Mental retardation | 21549014 | CNVD |
Williams Syndrome | 16617304 | CNVD |
Williams Syndrome | 20206275 | CNVD |
Williams Syndrome | 16199537 | CNVD |
Williams Syndrome | 18923514 | CNVD |
Williams Syndrome | 20970697 | CNVD |
Williams-beuren syndrome | 20926892 | CNVD |
Williams-beuren syndrome | 21808859 | CNVD |
periventricular nodular heterotopia | 20648244 | CNVD |
Williams Syndrome | 20425783 | CNVD |
Williams-beuren syndrome | 22226172 | CNVD |
Williams-beuren syndrome | 18923513 | CNVD |
Williams-beuren syndrome | 17565757 | CNVD |
Williams-beuren syndrome | 18787571 | CNVD |
Williams Syndrome | 22241247 | CNVD |
Autism | 21686962 | CNVD |
Autism | 20970697 | CNVD |
Epilepsy | 22118685 | CNVD |
Epilepsy | 20970697 | CNVD |
Mental retardation | 19951919 | CNVD |
Mental retardation | 21686962 | CNVD |
Schizophrenia | 22118685 | CNVD |
Williams-beuren syndrome | 18337728 | CNVD |
language delay | 21686962 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Prostate cancer | 16573809 | CNVD |
Mental retardation | 16773131 | CNVD |
Colorectal cancer | 19455253 | CNVD |
Williams-beuren syndrome | 16971481 | CNVD |
Idiopathic infantile hypercalcaemia | 20466674 | CNVD |
Williams Syndrome | 18308711 | CNVD |
Williams Syndrome | 19255058 | CNVD |
Williams Syndrome | 18924169 | CNVD |
Williams Syndrome | 21939500 | CNVD |
Williams Syndrome | 20425784 | CNVD |
Williams Syndrome | 22241097 | CNVD |
Williams Syndrome | 19176822 | CNVD |
Williams Syndrome | 17505701 | CNVD |
Supravalvular aortic stenosis | 19844261 | CNVD |
Williams Syndrome | 16760918 | CNVD |
Williams-beuren syndrome | 18452001 | CNVD |
Williams-beuren syndrome | 19880526 | CNVD |
Autism | 17666889 | CNVD |
speech delay | 17666889 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:71809200-71813800 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
2 | chr7:71810400-71813800 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
3 | chr7:71813200-71814200 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
4 | chr7:71813400-71814000 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
5 | chr7:71813400-71814200 | Enhancers | HUES64 Cell Line | embryonic stem cell |
6 | chr7:71813400-71814600 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
7 | chr7:71813600-71814200 | Enhancers | HUES48 Cell Line | embryonic stem cell |
8 | chr7:71813600-71814400 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
9 | chr7:71813800-71814000 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
10 | chr7:71813800-71814000 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
11 | chr7:71814000-71814400 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
12 | chr7:71814000-71814400 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
13 | chr7:71814200-71814800 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |
14 | chr7:71814400-71814800 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
15 | chr7:71814400-71814800 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
16 | chr7:71814800-71815000 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
17 | chr7:71821600-71822400 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
18 | chr7:71821800-71822200 | Flanking Active TSS | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
19 | chr7:71821800-71822400 | Active TSS | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
20 | chr7:71822000-71822400 | Active TSS | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
21 | chr7:71822200-71822400 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
22 | chr7:71822200-71822600 | Enhancers | H1 Cell Line | embryonic stem cell |
23 | chr7:71831600-71832000 | Enhancers | Fetal Heart | heart |